Physician profile
Michael Schiraldi
NPI 1326418757
$1,487.95
in general payments reported to CMS, 2019-2025
13 companies · $55.17 in 2025
The $55.17 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124 · 2020: $265 · 2021: $484 · 2022: $60.03 · 2023: $182 · 2024: $318 · 2025: $55.17.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $555.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $554.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $493.82 | 2019-2021 | |
| Aesculap, INC. | $198.63 | 2021-2023 | Aesculap, M.Blue |
| Integra Lifesciences Corporation | $191.00 | 2021-2024 | Codman Certas, Codman Hakim, Cusa Clarity |
| Medtronic, INC. | $167.52 | 2023-2024 | Infinity Occipitocervical Upper Thoracic System, Pyramid +4 Anterior Lumbar Plate System, Solitaire X |
| Penumbra, INC. | $155.98 | 2019-2025 | Red 72, Benchmark, Penumbra Coil 400 |
| Viz.Ai, INC. | $60.00 | 2021 | |
| Balt USA, LLC | $49.92 | 2021 | |
| Globus Medical, INC. | $42.00 | 2024 | Simplify Cervical Artificial Disc, Coalition Mis / Mis Ti, Acp |
| Bioventus LLC | $35.02 | 2025 | Bonescalpel & Sonicone (O.R.) |
| Abbvie INC. | $29.46 | 2024 | |
| Nevro Corp. | $24.27 | 2024 | Senza |
| Cordis US Corp. | $22.39 | 2022 | |
| Nuvasive, INC. | $17.94 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Schiraldi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.